| Purpose | Patients | Evaluations | Perceived Effectiveness |
|---|---|---|---|
| Heart attack (myocardial infarction) | 11 | 2 | |
| Prevent blood clotting | 7 | 6 | |
| Coronary artery disease | 5 | 5 | |
| Angina pectoris | 1 | 1 | |
| Antiphospholipid antibody syndrome | 1 | 0 |
Common side effects
| Side effect | Patients | Percentage |
|---|---|---|
| Bruising | 2 | |
| Excessive bleeding | 1 | |
| Headaches | 1 | |
| Subdural hematoma | 1 |
Side effect severity
| Severity | Evaluations | Percentage |
|---|---|---|
| Severe | 1 | |
| Moderate | 3 | |
| Mild | 3 | |
| None | 4 |